Navigation Links
Novavax Says Bird Flu Vaccines Effective

Novavax Inc. said Monday its virus-like particle vaccines were effective in preclinical studies in protecting// against different strains of the bird flu virus, and its shares surged in after-hours trading.

The studies involved two of Novavax's H5N1 influenza virus-like particle, or VLP vaccines, one targeting the Indonesia strain of pandemic flu and another targeting the Viet Nam strain. Mice and ferrets inoculated with each vaccine were protected when challenged with both strains of the virus.

The studies were conducted in collaboration with the University of Pittsburgh, and the data was submitted for peer-review publication. The U.S. Centers for Disease Control and Prevention also will conduct live challenge studies using Novavax's VLP pandemic influenza vaccines, according to a company release.

"We expect the CDC to further confirm these new data before we enter the clinic this year," Rick Bright, Novavax's vice president of global influenza programs, said in a release.

Shares of Novavax added 33 cents, or 8.1 percent, to $4.42 in aftermarket activity, after gaining 2 cents to end at $4.09 on the Nasdaq Stock Market where they have traded between $2.84 and $8.39 in the past year.



Source: Bio-Bio Technology
SRI
'"/>




Page: 1

Related medicine news :

1. Producing Vaccines from genetically modified crops
2. Understanding Chronic Infections May Help in Developing Therapeutic Vaccines
3. New Anthrax Vaccines Will Take time
4. Success Of Preventable High-Risk HPV Infections With Vaccines May Vary
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
7. Oral Edible vaccine for Allergy Vaccines
8. South Africa May Start Manufacturing Bird Flu Vaccines
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. From Computers to Vaccines
11. India To Produce More Cost Effective Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Finn Mouseson”: ... take precedence in an average life. This mouse sets out on a journey that ... heart. “Finn Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe ... creation of published author, Brooks Rathell. , “We typically hear about the favor of ... financial favor of God. Not only does it exist, but it is meant for ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
(Date:9/19/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Swirl: A Wine Tasting Event series on Thursday, October 26, 2017. Hosted at ...
(Date:9/19/2017)... MD (PRWEB) , ... September 19, 2017 , ... ... the Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” ... for SPBA Members as it focused on best practices for third party administrators ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 7, 2017 Caris Life Sciences, a ... the promise of precision medicine, today announced results ... of its molecular profiling approach in guiding therapeutic ... profiling plus (CGP+) with Caris Molecular Intelligence ® ... a molecular level, leading to more therapeutic options ...
Breaking Medicine Technology: